NCT04591353View on ClinicalTrials.gov

Trial Comparing Impact of PENG Block on Quality of Recovery Compared to No-block for Primary Total Hip Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

November 1, 2022

Conditions
Total Hip Arthroplasty
Interventions
DRUG

PENG Block

The pericapsular nerve group (PENG) block is a novel regional anesthesia technique for providing analgesia after hip fractures and hip arthroplasties.

DRUG

Lidocaine

2-3 cc of 2% lidocaine and NO bolus of bupivacaine will be injected.

Trial Locations (2)

35233

University of Alabama at Birmingham, Birmingham

35249

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT04591353 - Trial Comparing Impact of PENG Block on Quality of Recovery Compared to No-block for Primary Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter